As STS is a poorly differentiated neoplasm, it requires confirmation by immunohistochemistry.8, 28 The disease demonstrates positivity for endothelial cell markers such as factor VIII and anti-CD34 and anti-CD31 antibodies, the latter being the one with greater sensitivity and specificity.29, 30. The gene discussed is CD34; the disease is telomere syndrome.